NCT05985824Completed
The Effect of Pranayama Breathing Exercise on Quality of Life in Lung Cancer Patients
Comparison of the Effect on the Quality of Life of Lung Cancer Patients Who Underwent Prnayama Breathing Exercise and Did Not Apply Any Exercise.
Source: ClinicalTrials.gov · Last updated 29 May 2025
Brief summary (registry, in English)
This research is a randomized controlled experimental study to determine the effect of pranayama breathing exercise applied to patients with lung cancer on quality of life.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 1 Aug 2023
- Start date
- 6 Jan 2023
- Primary completion date
- 27 Jan 2024
- Lead sponsor
- Sanko University
- Diseases
- Lung cancer
- NCT number
- NCT05985824
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 6 Jan 2023 to the primary completion date, 27 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving radiotherapy,
Other illness
- Lung Cancer I., II., stage,
- Having a history of Brain Metastasis,
Age
- For patients over 65 years of age, patients with a score below 24 on the mini mental test were not included in the study.
- Research Termination Criteria
- Intervention Group
Other
- Using integrated health practices in the treatment process,
- Those who exercise regularly
- Developing additional health problems,
- Unwilling to continue the practice of pranayama breathing exercise,
- Those who lost their lives during the research process,
- Those who do not practice pranayama breathing exercise as recommended or cannot do it effectively,
- The study will be terminated with patients who want to withdraw from the study.
- Control Group
- Developing additional health problems,
- Those who lost their lives during the research process,
- The study will be terminated with patients who want to withdraw from the study.
Who the study is looking for
- Over 18 years old,
- Lung Cancer Stage III and IV,
- Being literate,
- Having sufficient communication skills,
- Does not have any ailment that will reduce the ability to comprehend and understand,
- Agreeing to participate in the research,
- Knowing the diagnosis,
- Receiving chemotherapy treatment,
- ECOG performance score ≤ 2,
- Not using opioids or sedating drugs,
- Patients who can use smart phones themselves or their relatives will be included in the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Erciyes University Coordinator of this site? Confirm its status | Kayseri | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.